Determinants of false-negative results in non-small-cell lung cancer staging by endobronchial ultrasound-guided needle aspiration

José Sanz-Santos, Mireia Serra, Miguel Gallego, Concepción Montón, Borja Cosio, Jaume Sauleda, Alberto Fernández-Villar, Ricardo García-Luján, Eduardo de Miguel, Rosa Cordovilla, Gonzalo Varela, Enrique Cases, Felipe Andreo, Eduard Monsó

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Abstract

© The Author 2014. OBJECTIVES: False-negative results of endobronchial ultrasound-guided transbronchial needle aspiration in non-small-cell lung cancer staging have shown significant variability in previous studies. The aim of this study was to identify procedure- and tumour-related determinants of endobronchial ultrasound-guided transbronchial needle aspiration false-negative results. METHODS: We conducted a prospective study that included non-small-cell lung cancer patients staged as N0/N1 by endobronchial ultrasound-guided transbronchial needle aspiration and undergoing therapeutic surgery. The frequency of false-negative results in the mediastinum was calculated. Procedure-related, first, and tumour-related, second, determinants of false-negative results in stations reachable and non-reachable by endobronchial ultrasound were determined by multivariate logistic regression. RESULTS: False-negative endobronchial ultrasound-guided transbronchial needle aspiration results were identified in 23 of 165 enrolled patients (13.9%), mainly in stations reachable by endobronchial ultrasound (17 cases, 10.3%). False-negative results were related to the extensiveness of endobronchial ultrasound sampling: their prevalence was low (2.4%) when sampling of three mediastinal stations was satisfactory, but rose above 10% when this requirement was not fulfilled (P = 0.043). In the multivariate analysis, abnormal mediastinum on computer tomography/positron emission tomography [odds ratio (OR) 7.77, 95% confidence interval (CI) 2.19-27.51, P = 0.001] and extensiveness of satisfactory sampling of mediastinal stations (OR 0.37, 95% CI 0.16-0.89, P = 0.026) were statistically significant risk factors for false-negative results in stations reachable by endobronchial ultrasound. False-negative results in non-reachable nodes were associated with a left-sided location of the tumour (OR 10.11, 95% CI 1.17-87.52, P = 0.036). CONCLUSIONS: The presence of false-negative ultrasound-guided transbronchial needle aspiration results were observed in nearly 15% of non-small-cell lung cancer patients but in only 3% when satisfactory samples were obtained from three mediastinal stations. False-negative results in stations reachable by endobronchial ultrasound were associated with the extensiveness of sampling, and in stations out of reach of endobronchial ultrasound with left-sided tumours. These results suggest that satisfactory sampling of at least three mediastinal stations by EBUS-TBNA may be a quality criterion to be recommended for EBUS-TBNA staging.
Original languageEnglish
Article numberezu253
Pages (from-to)642-647
JournalEuropean Journal of Cardio-thoracic Surgery
Volume47
Issue number4
DOIs
Publication statusPublished - 1 Apr 2015

Keywords

  • Endobronchial ultrasound-guided transbronchial needle aspiration
  • False negative
  • Mediastinum
  • Non-small-cell lung cancer
  • Staging

Fingerprint Dive into the research topics of 'Determinants of false-negative results in non-small-cell lung cancer staging by endobronchial ultrasound-guided needle aspiration'. Together they form a unique fingerprint.

Cite this